Insight Molecular Diagnostics Stock Gross Profit
| IMDX Stock | 7.16 0.34 4.53% |
By evaluating key metrics such as revenue growth, profitability, cash flow trends, and balance sheet strength, investors can better assess Insight Molecular's long-term financial health and intrinsic value.
| Last Reported | Projected for Next Year | ||
| Gross Profit | 851 K | 893.5 K | |
| Gross Profit Margin | 0.35 | 0.37 |
Insight | Gross Profit | Build AI portfolio with Insight Stock |
Insight Molecular Diagnostics Company Gross Profit Analysis
Insight Molecular's Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.
Current Insight Molecular Gross Profit | 2.09 M |
Most of Insight Molecular's fundamental indicators, such as Gross Profit, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Insight Molecular Diagnostics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Insight Gross Profit Driver Correlations
Understanding the fundamental principles of building solid financial models for Insight Molecular is extremely important. It helps to project a fair market value of Insight Stock properly, considering its historical fundamentals such as Gross Profit. Since Insight Molecular's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Insight Molecular's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Insight Molecular's interrelated accounts and indicators.
Click cells to compare fundamentals
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.
| Competition |
According to the company disclosure, Insight Molecular Diagnostics reported 2.09 M of gross profit. This is 99.91% lower than that of the Health Care Equipment & Supplies sector and 99.77% lower than that of the Health Care industry. The gross profit for all United States stocks is 99.99% higher than that of the company.
Insight Gross Profit Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Insight Molecular's direct or indirect competition against its Gross Profit to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Insight Molecular could also be used in its relative valuation, which is a method of valuing Insight Molecular by comparing valuation metrics of similar companies.Insight Molecular is currently under evaluation in gross profit category among its peers.
Insight Molecular ESG Sustainability
Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Insight Molecular's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Insight Molecular's managers, analysts, and investors.Environmental | Governance | Social |
Insight Fundamentals
| Return On Equity | -4.29 | ||||
| Return On Asset | -0.22 | ||||
| Operating Margin | (2.73) % | ||||
| Current Valuation | 54.24 M | ||||
| Shares Outstanding | 28.6 M | ||||
| Shares Owned By Insiders | 22.03 % | ||||
| Shares Owned By Institutions | 56.30 % | ||||
| Number Of Shares Shorted | 146.31 K | ||||
| Price To Book | 8.00 X | ||||
| Price To Sales | 22.55 X | ||||
| Revenue | 1.88 M | ||||
| Gross Profit | 2.09 M | ||||
| EBITDA | (59.02 M) | ||||
| Net Income | (60.66 M) | ||||
| Total Debt | 3.66 M | ||||
| Book Value Per Share | 0.36 X | ||||
| Cash Flow From Operations | (20.71 M) | ||||
| Short Ratio | 6.44 X | ||||
| Earnings Per Share | (3.79) X | ||||
| Target Price | 5.42 | ||||
| Number Of Employees | 46 | ||||
| Beta | 0.99 | ||||
| Market Capitalization | 86.66 M | ||||
| Total Asset | 35.08 M | ||||
| Retained Earnings | (350.54 M) | ||||
| Working Capital | 4.48 M | ||||
| Net Asset | 35.08 M |
About Insight Molecular Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Insight Molecular Diagnostics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Insight Molecular using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Insight Molecular Diagnostics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| JBL | Jabil Circuit | |
| MRK | Merck Company | |
| AMGN | Amgen Inc |
Additional Tools for Insight Stock Analysis
When running Insight Molecular's price analysis, check to measure Insight Molecular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Insight Molecular is operating at the current time. Most of Insight Molecular's value examination focuses on studying past and present price action to predict the probability of Insight Molecular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Insight Molecular's price. Additionally, you may evaluate how the addition of Insight Molecular to your portfolios can decrease your overall portfolio volatility.